• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany
 
  • Details
  • Full
Options
2025
Journal Article
Title

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

Author(s)
Buttmann, Mathias
Caritas-Krankenhaus Bad Mergentheim
Weber, Martin S.
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Meuth, Sven Günther
Universitätsklinikum Düsseldorf
Blümich, Sandra L.E.
Roche Pharma AG
Hieke-Schulz, Stefanie
Roche Pharma AG
Dirks, Petra
F. Hoffmann-La Roche AG
Eggebrecht, Julius C.
Roche Pharma AG
Ziemssen, Tjalf
Universitätsklinikum Carl Gustav Carus Dresden
Journal
Frontiers in Neurology
Funder
Roche
Open Access
DOI
10.3389/fneur.2025.1564327
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • effectiveness

  • humanized monoclonal anti-CD20 antibody

  • neurodegenerative diseases

  • non-interventional study (NIS)

  • ocrelizumab

  • real-world cohort

  • Relapsing multiple sclerosis

  • treatment success

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024